Dr Metab Alfohaidi

Present Title and AffiliationMedical Oncology Consultant – Breast Cancer Sub-specialty

Princess Noorah Oncology Center – National Guard Health Affairs, Jeddah

Assistant Professor &

Medical Oncology Block Cordinator

King Saud Bin Abdulaziz University for Health and Science – Jeddah

Western Oncology Group Director

Saudi Oncology Society

14 : 10 – 14 : 20

23 June | 2023 Day 1

3-year invasive disease-free survival (iDFS) of the strategy-based, randomized phase II PHERGain trial evaluating chemotherapy (CT) de-escalation in human epidermal growth factor receptor 2-positive (HER2[+]) early breast cancer (EBC).